MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government_Funders & Regulators
*Government: International
Europe
*Europe: Regions
*Western Europe
Switzerland
*Industry: Switzerland
Symetis AG
Attachments
Symetis SA
Parents
*Architects: Cardiovascular, Cardiac & Cardiology Companies _ Heart Valves, Ventricular Assist (LVAD,pVAD), Artificial Heart
*Industry: Switzerland
Companies: Acquired_(M&A)
Finance & Acquisitions: Boston Scientific
Texas Cardiovascular Innovative Ventures
Truffle Capital
Children
Announced that it has raised CHF 25 million ($25.8 million) in a new financing round co-led by Endeavour Vision and NBGI Venture
Existing investors Truffle Capital, Novartis Venture Fund, Wellington Partners, Vinci Capital - Renaissance PME, Banexi Ventures
Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.
Symetis SA, a private Swiss company developing new transcatheter aortic valve implantation (TAVI) systems